Cargando…
Low-Dose rIL-15 Protects from Nephrotoxic Serum Nephritis via CD8(+) T Cells
Rapid progressive glomerulonephritis (GN) often leads to end-stage kidney disease, driving the need for renal replacement therapy and posing a global health burden. Low-dose cytokine-based immunotherapies provide a new strategy to treat GN. IL-15 is a strong candidate for the therapy of immune-media...
Autores principales: | Mooslechner, Agnes A., Schuller, Max, Artinger, Katharina, Kirsch, Alexander H., Schabhüttl, Corinna, Eller, Philipp, Rosenkranz, Alexander R., Eller, Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688325/ https://www.ncbi.nlm.nih.gov/pubmed/36429085 http://dx.doi.org/10.3390/cells11223656 |
Ejemplares similares
-
Agonism of Prostaglandin E2 Receptor 4 Ameliorates Tubulointerstitial Injury in Nephrotoxic Serum Nephritis in Mice
por: Aringer, Ida, et al.
Publicado: (2021) -
The Spleen Plays No Role in Nephrotoxic Serum Nephritis, but Constitutes a Place of Compensatory Haematopoiesis
por: Artinger, Katharina, et al.
Publicado: (2015) -
B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response
por: Schuller, Max, et al.
Publicado: (2022) -
Innate and adaptive immunity in experimental glomerulonephritis: a pathfinder tale
por: Artinger, Katharina, et al.
Publicado: (2016) -
A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder
por: Frauscher, Bianca, et al.
Publicado: (2017)